5XSR
novel orally efficacious inhibitors complexed with PARP1
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL17U1 |
Synchrotron site | SSRF |
Beamline | BL17U1 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2015-12-14 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 0.9791 |
Spacegroup name | P 65 2 2 |
Unit cell lengths | 94.080, 94.080, 225.420 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 47.040 - 2.300 |
R-factor | 0.2134 |
Rwork | 0.213 |
R-free | 0.23340 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4hhy |
RMSD bond length | 0.009 |
RMSD bond angle | 0.906 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | PHASER |
Refinement software | PHENIX (1.11.1_2575) |
Data quality characteristics
Overall | Inner shell | Outer shell | |
Low resolution limit [Å] | 47.040 | 47.040 | 2.360 |
High resolution limit [Å] | 2.300 | 10.290 | 2.300 |
Rmerge | 0.105 | 0.052 | 0.879 |
Rmeas | 0.110 | 0.055 | 0.920 |
Number of reflections | 49570 | 549 | 3648 |
<I/σ(I)> | 15.41 | 34.38 | 3.27 |
Completeness [%] | 100.0 | 98.6 | 100 |
Redundancy | 11.495 | 11.077 | 11.582 |
CC(1/2) | 0.999 | 0.999 | 0.882 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 80mM NaCl, 1.9M (NH4)2SO4 |